Neuronetics Picks Up An Activist As Cannell Capital Seeks Board Seat
Wyoming-based activist firm Cannell Capital said this week that it’s accumulated a just under 13% stake in medical technology firm Neuronetics Inc (NASDAQ:STIM) and wants to put a director on the board at the company. The fund, run by J. Carlo Cannell, said it bought the shares between February 22 and June 1 for $3.5 million. The position accounts for just over two percent of Cannell’s assets under management. Q1 2022 hedge fund letters, conferences and more Cannell Capital said it and its investment group bought the shares as a long term investment and "not with the intent to change or influe...